Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 11: Albendazole is effective against all of the following helminths except:

A. Roundworm
B. Hookworm
C. Tapeworm (Correct Answer)
D. Pinworm

Explanation: **Explanation:** Albendazole is a broad-spectrum anthelmintic belonging to the **Benzimidazole** group. Its primary mechanism of action involves inhibiting **microtubule synthesis** by binding to β-tubulin, which leads to glucose depletion and the eventual death of the parasite. **Why Tapeworm is the correct answer (the exception):** While Albendazole has some activity against certain larval forms of cestodes (e.g., Neurocysticercosis caused by *T. solium* or Hydatid disease by *Echinococcus*), it is **not** the drug of choice for adult intestinal tapeworms. For adult tapeworm infestations, **Praziquantel** or **Niclosamide** are significantly more effective and are considered the standard treatments. **Why the other options are incorrect:** * **Roundworm (*Ascaris lumbricoides*):** Albendazole is highly effective and considered a first-line treatment for Ascariasis. * **Hookworm (*Ancylostoma duodenale/Necator americanus*):** Albendazole is the preferred agent for hookworm infections, often used in mass deworming programs. * **Pinworm (*Enterobius vermicularis*):** Albendazole is the drug of choice. A single dose repeated after two weeks is standard therapy to prevent reinfection. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Albendazole is the DOC for **Hydatid disease** (*E. granulosus*) and **Neurocysticercosis**. * **Absorption:** Its absorption is significantly **increased when taken with a fatty meal**, which is crucial when treating systemic infections (like Hydatid cysts). * **Contraindication:** It is generally avoided during **pregnancy** due to potential embryotoxic and teratogenic effects. * **Mebendazole vs. Albendazole:** Albendazole is preferred over Mebendazole for systemic infections because it is better absorbed from the GI tract.

Question 12: What is the drug of choice for amoebic liver abscess?

A. Metronidazole (Correct Answer)
B. Ciprofloxacin
C. Emetine
D. Chloroquine

Explanation: **Explanation:** **Metronidazole** is the drug of choice (DOC) for **amoebic liver abscess (ALA)** and all forms of invasive amoebiasis [1]. It is a nitroimidazole that acts as a potent tissue amoebicide. It is rapidly absorbed from the GI tract and achieves high therapeutic concentrations in the liver, effectively killing the trophozoites of *Entamoeba histolytica*. **Analysis of Options:** * **Metronidazole (Correct):** It is the first-line treatment due to its high efficacy and safety profile [2]. Following a course of Metronidazole, a **luminal amoebicide** (e.g., Diloxanide furoate or Paromomycin) must be administered to eradicate any surviving cysts in the colon and prevent relapse [1]. * **Ciprofloxacin:** This is a fluoroquinolone antibiotic used for bacterial infections (like bacillary dysentery) but has no significant activity against *E. histolytica*. * **Emetine:** While a potent tissue amoebicide, it is now rarely used due to its high toxicity, particularly **cardiotoxicity** (arrhythmias and hypotension). It is reserved only for severe cases where nitroimidazoles are contraindicated. * **Chloroquine:** It reaches high concentrations in the liver and was historically used for ALA. However, it is less effective than Metronidazole and is now considered a second-line agent, usually used in combination with other drugs if Metronidazole fails. **High-Yield Clinical Pearls for NEET-PG:** * **DOC for Asymptomatic Cyst Passers:** Diloxanide furoate (Luminal amoebicide) [2]. * **Tinidazole/Secnidazole:** These are longer-acting congeners of Metronidazole often preferred for better compliance (shorter dosage schedule) [1]. * **Aspiration of ALA:** Not routinely required unless the abscess is large (>10 cm), at risk of rupture, or fails to respond to drug therapy within 72 hours. The aspirated pus typically resembles **"Anchovy sauce."**

Question 13: What is the drug of choice for Pneumocystis Pneumonia?

A. Cotrimoxazole (Correct Answer)
B. Penicillin
C. Itraconazole
D. Ivermectin

Explanation: **Explanation:** **Pneumocystis jirovecii Pneumonia (PCP)** is a life-threatening opportunistic fungal infection primarily seen in immunocompromised patients, such as those with HIV/AIDS (typically when CD4 counts fall below 200 cells/mm³). **Why Cotrimoxazole is the Correct Answer:** **Cotrimoxazole** (a fixed-dose combination of Sulfamethoxazole and Trimethoprim) is the **drug of choice** for both the treatment and prophylaxis of PCP. It works by inhibiting two consecutive steps in the fungal folic acid synthesis pathway (sequential blockade). Despite *P. jirovecii* being classified as a fungus, it lacks ergosterol in its cell wall, making standard antifungals ineffective and sulfonamides the gold standard. **Analysis of Incorrect Options:** * **B. Penicillin:** This is a beta-lactam antibiotic that targets bacterial cell wall synthesis (peptidoglycan). It has no activity against fungi or *Pneumocystis*. * **C. Itraconazole:** While an antifungal, it acts by inhibiting ergosterol synthesis. Since *Pneumocystis* lacks ergosterol, azoles are clinically ineffective. * **D. Ivermectin:** This is an antiparasitic agent used for helminthic infections (like Strongyloidiasis) and ectoparasites (like Scabies); it has no role in treating fungal pneumonia. **High-Yield Clinical Pearls for NEET-PG:** * **Alternative Drugs:** If a patient is allergic to sulfonamides, the second-line treatments include **Clindamycin + Primaquine**, **Pentamidine**, or **Atovaquone**. * **Steroid Add-on:** In moderate-to-severe PCP (PaO₂ < 70 mmHg or A-a gradient > 35 mmHg), **adjunctive corticosteroids** are added to reduce the inflammation caused by dying organisms. * **Prophylaxis:** Cotrimoxazole is started as primary prophylaxis in HIV patients when the **CD4 count is <200 cells/mm³**.

Question 14: Which of the following fluoroquinolones has the broadest spectrum of activity against bacteria?

A. Ciprofloxacin
B. Norfloxacin
C. Trovafloxacin (Correct Answer)
D. Nalidixic acid

Explanation: **Explanation:** The correct answer is **Trovafloxacin**. Fluoroquinolones are classified into generations based on their spectrum of activity. Trovafloxacin belongs to the **fourth generation**, which represents the broadest spectrum in this class. **Why Trovafloxacin is correct:** Fourth-generation fluoroquinolones (like Trovafloxacin and Moxifloxacin) retain the Gram-negative coverage of earlier generations but significantly enhance activity against **Gram-positive cocci** (especially *S. pneumoniae*) and **anaerobes** (like *Bacteroides fragilis*). Trovafloxacin was the first to offer reliable anaerobic coverage, making it the broadest agent among the options. **Why the other options are incorrect:** * **Nalidixic acid:** A first-generation quinolone with a very narrow spectrum, limited only to Gram-negative bacteria causing uncomplicated UTIs. It lacks systemic activity. * **Norfloxacin:** A second-generation fluoroquinolone. While it has improved Gram-negative coverage compared to Nalidixic acid, it has poor systemic distribution and minimal Gram-positive activity. * **Ciprofloxacin:** Also a second-generation agent. It is highly potent against Gram-negative bacteria (including *Pseudomonas*) but has relatively weak activity against Gram-positive organisms and lacks anaerobic coverage. **High-Yield Clinical Pearls for NEET-PG:** * **The "Respiratory Quinolones":** Levofloxacin, Moxifloxacin, and Gemifloxacin are called this due to their excellent activity against *Streptococcus pneumoniae*. * **Pseudomonas coverage:** Ciprofloxacin is the most potent fluoroquinolone against *Pseudomonas aeruginosa*. * **Safety Note:** Trovafloxacin is rarely used clinically today due to the risk of **severe hepatotoxicity**, but it remains a classic exam answer for the "broadest spectrum" question. * **Mechanism of Action:** They inhibit **DNA Gyrase** (Gram-negative) and **Topoisomerase IV** (Gram-positive).

Question 15: What is the mechanism of action of sulfonamides?

A. Inhibit bacterial cell wall synthesis
B. Inhibits translocation of mRNA
C. Inhibits folate synthesis (Correct Answer)
D. Inhibits bacterial respiration

Explanation: **Explanation:** **Mechanism of Action (Option C):** Sulfonamides are structural analogs of **Para-Amino Benzoic Acid (PABA)**. They act by competitively inhibiting the enzyme **Dihydropteroate Synthase (DHPS)**. In bacteria, PABA is a crucial precursor for the synthesis of Dihydrofolic acid. By mimicking PABA, sulfonamides prevent the formation of folic acid, which is essential for purine and DNA synthesis. Since humans obtain folic acid from their diet and lack the DHPS enzyme, sulfonamides exhibit selective toxicity toward bacteria. **Analysis of Incorrect Options:** * **Option A:** Inhibition of cell wall synthesis is the mechanism of **Beta-lactams** (Penicillins, Cephalosporins) and Glycopeptides (Vancomycin). * **Option B:** Inhibition of mRNA translocation is characteristic of **Macrolides** (e.g., Erythromycin) and Clindamycin, which bind to the 50S ribosomal subunit. * **Option D:** Inhibition of bacterial respiration is not a standard mechanism for primary classes of antibiotics; most act on cell walls, protein synthesis, or nucleic acid pathways. **High-Yield Clinical Pearls for NEET-PG:** 1. **Bacteriostatic vs. Bactericidal:** Sulfonamides are bacteriostatic alone but become bactericidal when combined with Trimethoprim (Cotrimoxazole). 2. **Sequential Blockade:** Trimethoprim inhibits the next step in the pathway—the enzyme **Dihydrofolate Reductase (DHFR)**. 3. **Resistance:** Occurs via increased PABA production or mutations in the DHPS enzyme. 4. **Adverse Effects:** Watch for **Kernicterus** in newborns, **Stevens-Johnson Syndrome**, and crystalluria (prevented by alkalinizing urine).

Question 16: Amphotericin-B is obtained from which organism?

A. Streptomyces nodosus (Correct Answer)
B. Streptomyces pimprina
C. Streptomyces nousseri
D. Streptomyces fragilis

Explanation: ### Explanation **Correct Option: A. Streptomyces nodosus** Amphotericin-B is a potent polyene antifungal agent. It was originally isolated in 1955 from **_Streptomyces nodosus_**, an actinomycete found in the soil of the Orinoco River valley in Venezuela. The name "Amphotericin" is derived from the drug's **amphoteric** nature (containing both acidic carboxyl and basic amino groups), which makes it poorly soluble in water at physiological pH. **Analysis of Incorrect Options:** * **B. Streptomyces pimprina:** This organism is the source of **Hamycin**, another polyene antifungal developed in India (at Hindustan Antibiotics Ltd, Pimpri). * **C. Streptomyces noursei:** This is the source of **Nystatin**, the first clinically useful polyene antifungal. It is used topically due to high systemic toxicity. * **D. Streptomyces fragilis:** This is a distractor; however, many other antibiotics are derived from the *Streptomyces* genus (e.g., *S. erythreus* for Erythromycin, *S. griseus* for Streptomycin). **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Binds to **ergosterol** in the fungal cell membrane, creating pores that lead to the leakage of intracellular ions (K⁺ and Mg²⁺), resulting in cell death. * **Spectrum:** It is the "Gold Standard" for most systemic fungal infections (Mucormycosis, Cryptococcosis, visceral Leishmaniasis). * **Adverse Effects:** * **Infusion-related:** Fever, chills ("Shake and Bake" phenomenon). * **Dose-limiting:** Nephrotoxicity (causes renal tubular acidosis and hypokalemia). * **Formulations:** Liposomal Amphotericin-B (L-AMB) is preferred as it reduces nephrotoxicity by targeting the drug specifically to macrophages and fungal cells.

Question 17: Which of the following drugs is NOT used in the treatment of multidrug-resistant tuberculosis?

A. Tobramycin (Correct Answer)
B. Amikacin
C. Ciprofloxacin
D. Clarithromycin

Explanation: **Explanation:** The treatment of Multidrug-Resistant Tuberculosis (MDR-TB)—defined as resistance to at least Isoniazid and Rifampicin—requires the use of second-line antitubercular drugs (ATDs). **1. Why Tobramycin is the correct answer:** While **Tobramycin** is an aminoglycoside, it has **no significant clinical activity against *Mycobacterium tuberculosis***. It is primarily used for *Pseudomonas aeruginosa* infections. In contrast, other aminoglycosides like Amikacin and Kanamycin (and the cyclic peptide Capreomycin) are potent second-line agents used to treat MDR-TB [1]. **2. Analysis of incorrect options:** * **Amikacin (Option B):** This is a key second-line injectable drug (Group C) used in MDR-TB regimens. It inhibits protein synthesis by binding to the 30S ribosomal subunit [2]. * **Ciprofloxacin (Option C):** Fluoroquinolones are the backbone of MDR-TB treatment [1]. While Levofloxacin and Moxifloxacin are now preferred due to higher efficacy, Ciprofloxacin is a second-generation fluoroquinolone with documented anti-mycobacterial activity [1]. * **Clarithromycin (Option D):** This macrolide is used as an adjuvant or "Group D3" drug in complex MDR-TB cases or specifically for *Mycobacterium avium* complex (MAC). **High-Yield Clinical Pearls for NEET-PG:** * **Definition of XDR-TB:** MDR-TB plus resistance to any fluoroquinolone AND at least one second-line injectable drug (Amikacin, Capreomycin, or Kanamycin). * **Newer Drugs:** Bedaquiline (inhibits ATP synthase) and Delamanid (inhibits mycolic acid synthesis) are now priority drugs for MDR-TB [1]. * **Drug of Choice for MAC:** Clarithromycin is the mainstay of treatment for *M. avium* complex.

Question 18: Time-dependent killing is exhibited by all the following drugs except:

A. Ceftriaxone
B. Vancomycin
C. Gentamicin (Correct Answer)
D. Meropenem

Explanation: ### Explanation The pharmacodynamics of antimicrobial agents are categorized based on whether their efficacy depends on the **duration of exposure** or the **peak concentration** achieved. **Why Gentamicin is the correct answer:** Gentamicin is an **Aminoglycoside**. Aminoglycosides, along with Fluoroquinolones and Daptomycin, exhibit **Concentration-dependent killing**. This means their bactericidal activity increases as the peak serum concentration ($C_{max}$) exceeds the Minimum Inhibitory Concentration (MIC) of the pathogen. These drugs also possess a significant **Post-Antibiotic Effect (PAE)**, allowing for once-daily (extended-interval) dosing. **Why the other options are incorrect:** * **Ceftriaxone (Cephalosporin) & Meropenem (Carbapenem):** Both belong to the **Beta-lactam** family. Beta-lactams are classic examples of **Time-dependent killers**. Their efficacy depends on the percentage of time the drug concentration remains above the MIC ($T > MIC$). Increasing the concentration far above the MIC does not increase the rate of killing. * **Vancomycin (Glycopeptide):** Vancomycin is primarily considered a time-dependent killer (specifically $AUC/MIC$ ratio dependent). It requires maintained therapeutic levels over time to ensure bacterial eradication. **High-Yield Clinical Pearls for NEET-PG:** 1. **Time-dependent ($T > MIC$):** Beta-lactams (Penicillins, Cephalosporins, Carbapenems), Linezolid, and Erythromycin. 2. **Concentration-dependent ($C_{max}/MIC$):** Aminoglycosides, Fluoroquinolones, Metronidazole, and Amphotericin B. 3. **Post-Antibiotic Effect (PAE):** This is the persistent suppression of bacterial growth after the drug level falls below the MIC. It is most pronounced with Aminoglycosides against Gram-negative bacteria. 4. **Dosing Strategy:** For time-dependent drugs, frequent dosing or continuous infusion is preferred; for concentration-dependent drugs, large single daily doses are often more effective and less toxic.

Question 19: Ivermectin is indicated in which of the following conditions?

A. Scabies
B. Intestinal nematode infection
C. Filariasis
D. All of the above (Correct Answer)

Explanation: **Explanation:** Ivermectin is a broad-spectrum antiparasitic agent derived from *Streptomyces avermitilis*. It works by binding to **glutamate-gated chloride channels** in invertebrate nerve and muscle cells, leading to hyperpolarization, paralysis, and death of the parasite. **Why "All of the above" is correct:** * **Scabies (Option A):** Ivermectin is the drug of choice for **crusted (Norwegian) scabies** and is used as a highly effective oral alternative to topical permethrin for classical scabies. * **Intestinal Nematodes (Option B):** It is the **drug of choice for Strongyloidiasis** (*Strongyloides stercoralis*). It is also effective against *Ascaris lumbricoides*, *Enterobius vermicularis*, and *Trichuris trichiura*. * **Filariasis (Option C):** Ivermectin is the drug of choice for **Onchocerciasis** (River Blindness) as it kills the microfilariae. It is also used in the mass drug administration (MDA) programs for **Lymphatic Filariasis** (often in combination with Albendazole). **High-Yield Clinical Pearls for NEET-PG:** 1. **Mechanism of Action:** Potentiates GABA-mediated neurotransmission and opens glutamate-gated chloride channels. 2. **Mazzotti Reaction:** A severe inflammatory response (fever, rash, joint pain) seen after treating Onchocerciasis with Ivermectin due to the rapid killing of microfilariae. 3. **Contraindication:** It should not be used in patients with a breached blood-brain barrier (e.g., meningitis, African Sleeping Sickness) because it can cross into the CNS and cause toxicity, as human GABA receptors are located in the brain. 4. **Drug of Choice Summary:** Remember Ivermectin for **S.O.S.** — **S**trongyloidiasis, **O**nchocerciasis, and **S**cabies (Crusted).

Question 20: In leprosy, which is considered the most effective bactericidal agent?

A. Clofazimine
B. Dapsone
C. Rifampicin (Correct Answer)
D. Ethionamide

Explanation: ### Explanation **Rifampicin** is the most potent bactericidal drug available for the treatment of leprosy. It acts by inhibiting the DNA-dependent RNA polymerase of *Mycobacterium leprae*. Its bactericidal activity is so profound that a single dose of 600 mg can kill more than 99.9% of viable bacilli within 3-7 days. Because of this rapid action, it renders the patient non-infectious very quickly, making it the backbone of Multi-Drug Therapy (MDT). **Analysis of Incorrect Options:** * **Dapsone (Option B):** While it is the oldest and most widely used drug for leprosy, it is primarily **bacteriostatic**. It works by inhibiting the enzyme dihydropteroate synthase (folate synthesis). Resistance develops easily if used as monotherapy. * **Clofazimine (Option A):** This is a dye that has weak **bacteriostatic** and anti-inflammatory properties. It is included in MDT primarily to prevent dapsone resistance and to control Type 2 Lepra reactions (ENL). * **Ethionamide (Option D):** This is a secondary drug used only as an alternative in cases of resistance or intolerance to standard MDT. It is less effective and more toxic than Rifampicin. **High-Yield Clinical Pearls for NEET-PG:** * **MDT Regimen (WHO):** * **Paucibacillary (PB):** Rifampicin + Dapsone for 6 months. * **Multibacillary (MB):** Rifampicin + Dapsone + Clofazimine for 12 months. * **Side Effects:** Dapsone can cause **hemolysis** (especially in G6PD deficiency) and "Dapsone Syndrome." Clofazimine causes **reddish-black skin discoloration** and ichthyosis. * **Drug of Choice for Type 2 Lepra Reaction:** Thalidomide (or Corticosteroids). * **Drug of Choice for Type 1 Lepra Reaction:** Corticosteroids (Prednisolone).

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free